Frontiers in Cardiovascular Medicine

Original Research

Published on 08 Dec 2021

Established Tumour Biomarkers Predict Cardiovascular Events and Mortality in the General Population

in Cardio-Oncology

Valentina Bracun
Navin Suthahar
Canxia Shi
Sanne de Wit
Wouter C. Meijers
IJsbrand T. Klip
Rudolf A. de Boer
Joseph Pierre Aboumsallem

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.753885

3,523 views
14 citations

Original Research

Published on 02 Dec 2021

Use of Anti-angiogenic Drugs Potentially Associated With an Increase on Serum AST, LDH, CK, and CK-MB Activities in Patients With Cancer: A Retrospective Study

in Cardio-Oncology

Qi Zheng
Hanzhou Wang
Wei Hou
Ying Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.755191

3,081 views
14 citations

Case Report

Published on 25 Nov 2021

Case Report: 3D Printing Guided Cardiac Autotransplantation for Treatment of a Giant Complex Primary Left Atrial Tumor

in Cardio-Oncology

Yang-zhao Zhou
Tao Tang
Cheng Luo
Xin-min Zhou
Xian-ming Fu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.800459

1,801 views
2 citations

Original Research

Published on 24 Nov 2021

Perceptions of the Cardiologists and Oncologists: Initial Step for Establishing Cardio-Oncology Service

in Cardio-Oncology

Hasan Ali Farhan
Israa Fadhil Yaseen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.704029

2,412 views
8 citations

Review

Published on 24 Nov 2021

MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review

in Cardio-Oncology

Liuying Chen
Yizhou Xu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.740515

4,461 views
10 citations

Systematic Review

Published on 19 Nov 2021

N-Acetylcysteine for Cardiac Protection During Coronary Artery Reperfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

in Cardio-Oncology

Sher Ali Khan
Ashley M. Campbell
Yingying Lu
Lingling An
Joseph S. Alpert
Qin M. Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.752939

13,268 views
19 citations

Review

Published on 19 Nov 2021

Tyrosine Kinase Inhibitors-Induced Arrhythmias: From Molecular Mechanisms, Pharmacokinetics to Therapeutic Strategies

in Cardio-Oncology

Mengfei Cheng
Fang Yang
Jiahui Liu
Dan Yang
Shuo Zhang
Yang Yu
Shuai Jiang
Mei Dong

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.758010

7,182 views
23 citations

Case Report

Published on 15 Nov 2021

Case Report: An Unusual Cause for Recurrent Hemopericardium in a Patient With Dyspnea

in Cardio-Oncology

Uyên Châu Nguyên
Astrid I. P. Vernemmen
Patrique Segers
Axel zur Hausen
Rob G. H. Driessen
Maurice J. H. M. Pluijmen
Sebastiaan C. A. M. Bekkers

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.755106

2,560 views

Case Report

Published on 12 Nov 2021

Case Report: A Tale of a Cardiac Mass: Looks Like a Papillary Fibroelastoma, Acts Like a Non-bacterial Thromboendocarditis

in Cardio-Oncology

Ali Ahmad
Arman Arghami
Edward A. El-Am
Thomas A. Foley
Reto D. Kurmann
Kyle W. Klarich

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.782926

4,273 views
2 citations

Original Research

Published on 11 Nov 2021

Cancer and Infective Endocarditis: Characteristics and Prognostic Impact

in Cardio-Oncology

Bernard Cosyns
Bram Roosens
Patrizio Lancellotti
Cécile Laroche
Raluca Dulgheru
Valentina Scheggi
Isidre Vilacosta
Agnès Pasquet
Cornelia Piper
Graciela Reyes

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.766996

5,791 views
14 citations

Original Research

Published on 08 Nov 2021

The Role of METTL3-Mediated N6-Methyladenosine (m6A) of JPH2 mRNA in Cyclophosphamide-Induced Cardiotoxicity

in Cardio-Oncology

Min Zhu
Yangong Liu
Yuanxiu Song
Shiqin Zhang
Chengwen Hang
Fujian Wu
Xianjuan Lin
Zenghui Huang
Feng Lan
Ming Xu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.763469

4,219 views
8 citations

Systematic Review

Published on 02 Nov 2021

Association Between Previous or Active Cancer and Clinical Outcomes in TAVR Patients: A Systematic Review and Meta-Analysis of 255,840 Patients

in Cardio-Oncology

Carlos Diaz-Arocutipa
Javier Torres-Valencia
Gabriela Zavaleta-Camacho
Lourdes Vicent

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.763557

2,756 views
5 citations

Original Research

Published on 29 Oct 2021

Clinical Profile and Prognosis of a Real-World Cohort of Patients With Moderate or Severe Cancer Therapy-Induced Cardiac Dysfunction

in Cardio-Oncology

Alberto Esteban-Fernández
Juan Fernando Carvajal Estupiñan
Juan José Gavira-Gómez
Sonia Pernas
Pedro Moliner
Alberto Garay
Álvaro Sánchez-González
Inmaculada Fernández-Rozas
José González-Costello

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.721080

3,221 views
12 citations

Original Research

Published on 25 Oct 2021

Cardiologic Long-Term Follow-Up of Patients Treated With Chest Radiotherapy: When and How?

in Cardio-Oncology

Chiara Lestuzzi
Maurizio Mascarin
Elisa Coassin
Maria Laura Canale
Fabio Turazza

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.671001

3,554 views
6 citations

Case Report

Published on 25 Oct 2021

Case Report: A Rare Case of a Ventricular Perivascular Epithelioid Cell Tumor With Histologic Characteristics That Resembled a Primary Cardiac Rhabdomyoma

in Cardio-Oncology

Jorge Cossío-Aranda
Alberto Aranda-Frausto
Joaquin Berarducci
Nilda Espinola-Zavaleta
Laila González-Melchor
Clara Vázquez-Antona
Gabriela Meléndez-Ramirez
Javier Ivan Armenta-Moreno
Candace Keirns

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.709328

1,589 views

Original Research

Published on 22 Oct 2021

Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer

in Cardio-Oncology

Henrike Arfsten
Anna Cho
Suriya Prausmüller
Georg Spinka
Johannes Novak
Georg Goliasch
Philipp E. Bartko
Markus Raderer
Heinz Gisslinger
Gabriela Kornek

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2021.725903

3,482 views
22 citations